Today I am republishing one of my long lost classic essays, “Who Will Decide Which Pedigree Model You Will Invest In?“. This essay was first published on November 15, 2010 but was removed from public view in December of that year. Next week I will republish the second long lost essay, “Standards and Guidance For U.S. Pharma Supply Chain Technology“, originally published on November 22, 2010. Both of these essay contain my thoughts on how the industry will eventually resolve the current confusion over which approach to ePedigree everyone in the U.S. supply chain should take. Check them out and see if you agree or not. Feel free to leave a comment to explain your take on this important question.
I hope your summer is going well. I’ve done some traveling and a lot of bike training for the Pelotonia. Stay tuned for the fall RxTrace writing season coming in September.
…a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance
DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of RxTrace. The material contained in RxTrace is not legal advice. The writers of RxTrace are not lawyers. The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating the positions of any company, organization or individual other than RxTrace.